Chokkalingam A. Risk of total non-hepatic cancer following treatment for HCV infection with direct-acting antiviral agents. PS-155.
Immunogeniciteit en reactogeniciteit van heterologe ChAdOx1 nCoV-19/mRNA-vaccinatie
dec 2021 | Vaccinatie, Virale infecties